Skip to main content
Healthcare

Domain-alteration chimeras rewire oncogenic complexes in prostate cancer

Domain-alteration chimeras rewire oncogenic complexes in prostate cancer

Feed excerpt — reported by Nature

Nature, Published online: 11 November 2026; doi:10.1038/s41586-026-11262-4A novel therapeutic modality enforces non-native androgen receptor (AR)–p300/CBP interactions to collapse AR transcriptional programs, producing super-inhibitory, lineage-selective suppression of metastatic prostate cancer and establishing domain-alteration chimeras as a broadly applicable therapeutic strategy leveraging induced proximity.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at Nature →

Original Source

This article was syndicated from Nature. All rights remain with the original publisher.